In breast cancer, overexpression of LAPTM4B leads to the sequestration of anthracycline, delaying its concentration in the nucleus, thereby inducing anthracycline resistance and ultimately breast cancer recurrence and metastasis [14]. The gene discussed is LAPTM4B; the disease is breast cancer.